On the question of the treatment of chronic hepatitis C with HIV co-infection in patients with lymphoma


Cite item

Full Text

Abstract

Due to the use of HAART, the efficacy of the treatment of AIDS-related lymphomas and indicators of survival in patients are close to those in the general population of lymphoma patients without HIV. According to the data of department of hematology and secondary immunodeficient conditions of Moscow Clinical Research Center 176 patients with lymphomas associated with HIV were treated for the period 2011-2015. The percentage of patients with hepatitis virus co-infection (C, B or C+B co-infection) is nearly 50%. Co-infection viral hepatitis, particularly hepatitis C virus (HCV) causes certain difficulties that, such as a more rapid progression of liver failure (development of cirrhosis and/or hepatocellular carcinoma). Use of new highly active drugs in viral infections treatment allows to increase the efficacy of the treatment of lymphomas associated with HIV and viral hepatitis. The treatment of HCV in HIV co-infected patients must be prioritized due to the rapid progression of liver failure.

About the authors

A V Chistyakova

People’s Friendship University of Russia

Email: 4istyakovaa@gmail.com
ассистент каф. госпитальной терапии с курсом клинической лабораторной диагностики Медицинского института ФГАОУ ВО РУДН, врач-гематолог 117198, Russian Federation, Moscow, ul. Miklukho-Maklaya, d. 6

N I Stuklov

People’s Friendship University of Russia

д-р мед. наук, проф. каф. госпитальной терапии с курсом клинической лабораторной диагностики Медицинского института ФГАОУ ВО РУДН 117198, Russian Federation, Moscow, ul. Miklukho-Maklaya, d. 6

M V Tumanova

Moscow Clinical Research Center of the Department of Health of Moscow

врач-гематолог, зав. отд-нием онкогематологии и вторичных иммунодефицитных состояний ГБУЗ МКНЦ 111123, Russian Federation, Moscow, sh. Enthusiastov, d. 86

M G Dubnitskaya

Moscow Clinical Research Center of the Department of Health of Moscow

врач-гематолог отд-ния онкогематологии и вторичных иммунодефицитных состояний ГБУЗ МКНЦ 111123, Russian Federation, Moscow, sh. Enthusiastov, d. 86

O V Mukhin

Moscow Clinical Research Center of the Department of Health of Moscow

канд. мед. наук, врач-гематолог отд-ния онкогематологии и вторичных иммунодефицитных состояний ГБУЗ МКНЦ 111123, Russian Federation, Moscow, sh. Enthusiastov, d. 86

E P Shtyrlina

Moscow Clinical Research Center of the Department of Health of Moscow

врач-гематолог отд-ния онкогематологии и вторичных иммунодефицитных состояний ГБУЗ МКНЦ 111123, Russian Federation, Moscow, sh. Enthusiastov, d. 86

A V Pivnik

Moscow Clinical Research Center of the Department of Health of Moscow

д-р мед. наук, проф., рук. отд. онкогематологии и вторичных иммунодефицитных заболеваний ГБУЗ МКНЦ 111123, Russian Federation, Moscow, sh. Enthusiastov, d. 86


Copyright (c) 2016 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies